Sarcopenic Obesity with Normal Body Size May Have Higher Insulin Resistance in Elderly Patients with Type 2 Diabetes Mellitus

References

• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Flegal KM, Shepherd JA, Looker AC, et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr. 2009;89(2):500–508. doi:10.3945/ajcn.2008.26847
   PubMed Web of Science ®Google Scholar
• Heo M, Faith MS, Pietrobelli A, Heymsfield SB. Percentage of body fat cutoffs by sex, age, and race-ethnicity in the US adult population from NHANES 1999–2004. Am J Clin Nutr. 2012;95(3):594–602. doi:10.3945/ajcn.111.025171
   PubMed Web of Science ®Google Scholar
• Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res. 2004;12(6):887–888. doi:10.1038/oby.2004.107
   PubMedGoogle Scholar
• Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437–448. doi:10.1111/j.1749-6632.2000.tb06498.x
   PubMed Web of Science ®Google Scholar
• Tremblay A, Royer MM, Chaput JP, Doucet E. Adaptive thermogenesis can make a difference in the ability of obese individuals to lose body weight. Int J Obes. 2013;37(6):759–764. doi:10.1038/ijo.2012.124
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Hirsch J, Gallagher DA, Leibel RL. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr. 2008;88(4):906–912. doi:10.1093/ajcn/88.4.906
   PubMed Web of Science ®Google Scholar
• Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701. doi:10.1093/ajcn/72.3.694
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol a Biol Sci Med Sci. 2006;61(10):1059–1064. doi:10.1093/gerona/61.10.1059
   PubMed Web of Science ®Google Scholar
• Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol a Biol Sci Med Sci. 2005;60(3):324–333. doi:10.1093/gerona/60.3.324
   PubMed Web of Science ®Google Scholar
• Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513–537. doi:10.1038/s41574-018-0062-9
   PubMed Web of Science ®Google Scholar
• Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017;35:200–221. doi:10.1016/j.arr.2016.09.008
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981;30(12):1000–1007. doi:10.2337/diab.30.12.1000
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest. 1985;76(1):149–155. doi:10.1172/JCI111938
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992;15(3):318–368. doi:10.2337/diacare.15.3.318
   PubMed Web of Science ®Google Scholar
• Draznin B, Aroda VR, Bakris G, et al. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–s38.
   PubMedGoogle Scholar
• World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;854:1–452.
   PubMed Web of Science ®Google Scholar
• Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191–2192. doi:10.2337/diacare.21.12.2191
   PubMed Web of Science ®Google Scholar
• Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–763. doi:10.1093/oxfordjournals.aje.a009520
   PubMed Web of Science ®Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian working group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e302. doi:10.1016/j.jamda.2019.12.012
   PubMed Web of Science ®Google Scholar
• Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1–203. doi:10.4158/EP161365.GL
   PubMed Web of Science ®Google Scholar
• Geloneze B, Vasques AC, Stabe CF, et al. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS). Arq Bras Endocrinol Metabol. 2009;53(2):281–287. doi:10.1590/S0004-27302009000200020
   PubMedGoogle Scholar
• Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368(9548):1681–1688. doi:10.1016/S0140-6736(06)69703-1
   PubMed Web of Science ®Google Scholar
• Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010;33(7):1497–1499. doi:10.2337/dc09-2310
   PubMed Web of Science ®Google Scholar
• Wang T, Feng X, Zhou J, et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci Rep. 2016;6:38937. doi:10.1038/srep38937
   PubMed Web of Science ®Google Scholar
• Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes. 2006;55(6):1813–1818. doi:10.2337/db05-1183
   PubMed Web of Science ®Google Scholar
• Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–2140. doi:10.1001/jama.2009.726
   PubMed Web of Science ®Google Scholar
• Kim JA, Hwang SY, Chung HS, et al. Proportion and characteristics of the subjects with low muscle mass and abdominal obesity among the newly diagnosed and drug-naïve type 2 diabetes mellitus patients. Diabetes Metab J. 2019;43(1):105–113. doi:10.4093/dmj.2018.0036
   Web of Science ®Google Scholar
• Trémollieres FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol. 1996;175(6):1594–1600. doi:10.1016/S0002-9378(96)70111-4
   PubMed Web of Science ®Google Scholar
• Sowers M, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab. 2007;92(3):895–901. doi:10.1210/jc.2006-1393
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Cappagli B, De Simone L, Orlandi R, Genazzani AR. Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas. 2001;39(2):125–132. doi:10.1016/S0378-5122(01)00194-3
   PubMed Web of Science ®Google Scholar
• Miller KK. Androgen deficiency: effects on body composition. Pituitary. 2009;12(2):116–124. doi:10.1007/s11102-008-0121-7
   PubMed Web of Science ®Google Scholar
• Sakuma K, Aoi W, Yamaguchi A. Current understanding of sarcopenia: possible candidates modulating muscle mass. Pflugers Archiv. 2015;467(2):213–229. doi:10.1007/s00424-014-1527-x
   Web of Science ®Google Scholar
• Kob R, Bollheimer LC, Bertsch T, et al. Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis? Biogerontology. 2015;16(1):15–29. doi:10.1007/s10522-014-9539-7
   Web of Science ®Google Scholar
• Apostolopoulos V, de Courten MP, Stojanovska L, Blatch GL, Tangalakis K, de Courten B. The complex immunological and inflammatory network of adipose tissue in obesity. Mol Nutr Food Res. 2016;60(1):43–57. doi:10.1002/mnfr.201500272
   PubMed Web of Science ®Google Scholar
• Exley MA, Hand L, O’Shea D, Lynch L. Interplay between the immune system and adipose tissue in obesity. J Endocrinol. 2014;223(2):R41–48. doi:10.1530/JOE-13-0516
   PubMed Web of Science ®Google Scholar
• Tateya S, Kim F, Tamori Y. Recent advances in obesity-induced inflammation and insulin resistance. Front Endocrinol. 2013;4:93. doi:10.3389/fendo.2013.00093
   PubMedGoogle Scholar
• Rivas DA, McDonald DJ, Rice NP, Haran PH, Dolnikowski GG, Fielding RA. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity. Am J Physiol Regul Integr Comp Physiol. 2016;310(7):R561–569. doi:10.1152/ajpregu.00198.2015
   Web of Science ®Google Scholar
• Muoio DM. Revisiting the connection between intramyocellular lipids and insulin resistance: a long and winding road. Diabetologia. 2012;55(10):2551–2554. doi:10.1007/s00125-012-2597-y
   Web of Science ®Google Scholar
• Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study. Eur J Appl Physiol. 2010;108(1):191–195. doi:10.1007/s00421-009-1192-5
   PubMed Web of Science ®Google Scholar
• Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2010;5(5):e10805. doi:10.1371/journal.pone.0010805
   PubMed Web of Science ®Google Scholar
• Kim TN, Park MS, Lim KI, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study. Clin Endocrinol (Oxf). 2013;78(4):525–532. doi:10.1111/j.1365-2265.2012.04433.x
   PubMed Web of Science ®Google Scholar
• Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr. 2013;56(1):270–278. doi:10.1016/j.archger.2012.09.007
   PubMed Web of Science ®Google Scholar
• Habib SS, Alkahtani S, Alhussain M, Aljuhani O. Sarcopenia coexisting with high adiposity exacerbates insulin resistance and dyslipidemia in Saudi adult men. Diabetes Metabol Syndr Obes. 2020;13:3089–3097. doi:10.2147/DMSO.S260382
   PubMed Web of Science ®Google Scholar
• National Health and Family Planning Commission of People’s Republic of China. Criteria of Weight for Adults. Vol. 2. Beijing, China: Standards Press of China; 2013.
   Google Scholar
• Jain SH, Massaro JM, Hoffmann U, et al. Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care. 2009;32(5):903–908. doi:10.2337/dc08-1733
   PubMed Web of Science ®Google Scholar
• Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301–1313. doi:10.1161/CIRCULATIONAHA.111.067264
   PubMed Web of Science ®Google Scholar